All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 195 points (-1.1%) at 16,964 as of Wednesday, Jan. 6, 2016, 11:55 AM ET. The NYSE advances/declines ratio sits at 842 issues advancing vs. 2,118 declining with 157 unchanged.

The Health Services industry currently sits down 0.2% versus the S&P 500, which is down 0.7%. A company within the industry that fell today was Opko Health ( OPK), up 2.6%. Top gainers within the industry include PRA Health ( PRAH), up 7.0%, Teleflex ( TFX), up 1.6% and Fresenius Medical Care AG & Co. KGaA ( FMS), up 0.9%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. St Jude Medical ( STJ) is one of the companies pushing the Health Services industry lower today. As of noon trading, St Jude Medical is down $0.62 (-1.0%) to $60.17 on average volume. Thus far, 741,684 shares of St Jude Medical exchanged hands as compared to its average daily volume of 1.7 million shares. The stock has ranged in price between $59.71-$60.33 after having opened the day at $59.98 as compared to the previous trading day's close of $60.79.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

St. Jude Medical, Inc., together with its subsidiaries, develops, manufactures and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide. St Jude Medical has a market cap of $17.1 billion and is part of the health care sector. Shares are down 1.6% year-to-date as of the close of trading on Tuesday. Currently there are 13 analysts that rate St Jude Medical a buy, 1 analyst rates it a sell, and 7 rate it a hold.

TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its notable return on equity, good cash flow from operations and expanding profit margins. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full St Jude Medical Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading, Becton Dickinson ( BDX) is down $0.96 (-0.7%) to $147.46 on average volume. Thus far, 714,084 shares of Becton Dickinson exchanged hands as compared to its average daily volume of 964,200 shares. The stock has ranged in price between $144.93-$147.73 after having opened the day at $145.99 as compared to the previous trading day's close of $148.42.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Becton, Dickinson and Company develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. Becton Dickinson has a market cap of $31.4 billion and is part of the health care sector. Shares are down 3.7% year-to-date as of the close of trading on Tuesday. Currently there are 9 analysts that rate Becton Dickinson a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Becton Dickinson as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations, solid stock price performance, expanding profit margins and reasonable valuation levels. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full Becton Dickinson Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading, Anthem ( ANTM) is down $1.80 (-1.3%) to $139.44 on light volume. Thus far, 446,936 shares of Anthem exchanged hands as compared to its average daily volume of 2.1 million shares. The stock has ranged in price between $138.38-$140.48 after having opened the day at $140.03 as compared to the previous trading day's close of $141.24.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial and Specialty Business, Government Business, and Other. Anthem has a market cap of $36.3 billion and is part of the health care sector. Shares are up 1.3% year-to-date as of the close of trading on Tuesday. Currently there are 9 analysts that rate Anthem a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Anthem as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full Anthem Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).